Efficacy and Adverse Events During Janus Kinase Inhibitor Treatment of SAVI Syndrome

S. Volpi, A. Insalaco, R. Caorsi, E. Santori, V. Messia, O. Sacco, S. Terheggen-Lagro, F. Cardinale, A. Scarselli, C. Pastorino, G. Moneta, G. Cangemi, C. Passarelli, M. Ricci, D. Girosi, M. Derchi, P. Bocca, A. Diociaiuti, M. El Hachem, C. CancriniP. Tomà, C. Granata, A. Ravelli, F. Candotti, P. Picco, F. DeBenedetti, M. Gattorno

Research output: Contribution to journalArticle

Cite this

Volpi, S., Insalaco, A., Caorsi, R., Santori, E., Messia, V., Sacco, O., Terheggen-Lagro, S., Cardinale, F., Scarselli, A., Pastorino, C., Moneta, G., Cangemi, G., Passarelli, C., Ricci, M., Girosi, D., Derchi, M., Bocca, P., Diociaiuti, A., El Hachem, M., ... Gattorno, M. (2019). Efficacy and Adverse Events During Janus Kinase Inhibitor Treatment of SAVI Syndrome. Journal of Clinical Immunology, 39(5), 476-485. https://doi.org/10.1007/s10875-019-00645-0